At WinLux Biomedicine Technology Co., Ltd., a subsidiary of Chainwin Agriculture and Animal Technology Global Business Group, we strive to set the standard for quality, safety, and value in the discovery, research, and development in the healthcare industry. Our aim includes establishing diseases database, multiplex diagnostic platform, and devoting in new drug development. Throughout our work, WinLux is committed to being transparent, acting with integrity, protecting the environment, and respecting human rights.

Led by the Chairman Chen, Jin-Cai, WinLux reveals its core values from the basis of everything we do: Accountability, Innovation, Quality Foremost, and Life Respect. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we shall keep accomplishing ultimate goals, “to make a difference for all who rely on us.”